Third quarter July-September 2014
· Order intake was SEK 842 (232) million
· Net sales were SEK 338 (220) million
· EBIT was SEK 37 (9) million
· Earnings per share was SEK 0.31 (0.00)
Interim period January-September 2014
· Order intake was SEK 1,410 (679) million
· Net sales were SEK 819 (672) million
· EBIT was SEK 45 (-10) million
· Earnings per share was SEK 0.34 (-0.21)
Outlook
The assessment for sales in 2014 remains unchanged from the previous
quarter. The company´s assessment is that sales in 2014 will be in the span of
SEK 1,150 – 1,250 million.
Stronger order intake in several areas
The order intake is demonstrating growth, but this is also an indicator of the
fluctuations that occur, especially within the PG market. During the first nine
months, the Group received orders for seven mask writers. The trend towards
increasingly advanced electronics products drives demand for complex photomasks
for use in the manufacture of displays for these products. At the same time the
customers’ utilization of existing equipment has been high. Together, the two
factors have led to customers starting to invest in new equipment. However,
investment in mask writers has not been solely in advanced equipment for
manufacturing of displays, but also for other segments.
“We are happy to have succeeded in matching our offering within business area PG
with various needs within several different market segments. This has resulted
in a number of orders during the third quarter”, says Lena Olving, CEO and
President of Mycronic AB.
The market for SMT equipment has also remained favorable. During the third
quarter, Mycronic saw an increase in both the order intake and sales, as has
been the case during the entire interim period. The consolidated EBIT remains
positive for the fifth consecutive quarter. Cash flow, excluding an extra
dividend of 245 MSEK, which was paid out in August, reached SEK 167 million
during the third quarter.
By delivering new products in tandem with customers’ changing requirements, and
by simultaneously maintaining cost levels, Mycronic has created good conditions
for long term profitability. “We are continuing to strengthen our brand, which
positions us as an important supplier of effective production solutions. We are
pleased to report a good third quarter, but it is also important to point out
that while these types of investments can occur at the same time, this is not a
typical quarter”, says Lena Olving.
About Mycronic
Mycronic AB is a high-tech Swedish company engaged in the development,
manufacturing and marketing of production equipment to the electronics industry.
Mycronic headquarters is located in Täby, north of Stockholm and the Group has
subsidiaries in China, France, Germany, Japan, Singapore, South Korea, Taiwan,
the Netherlands, United Kingdom and the US. For more information, see our web
site at www.mycronic.com.
Mycronic AB (publ) is listed on NASDAQ Stockholm, Small Cap: MYCR.
This interim report is a translation of the Swedish version. In the event of any
differences between this translation and the Swedish original version, the
Swedish version shall have precedence.
